SCOPUS 정보 검색 플랫폼

Investigational New Drugs

Volumn 20, Issue 1, 2002, Pages 129-132

Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study

(6) Budd, G Thomas a Rankin, Cathryn b Hutchins, Laura F c Wong, Lucas d Petruska, Paul J e Antman, Karen f

a LERNER RESEARCH INSTITUTE (United States)

b Statistical Center (United States)

c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES (United States)

d SCOTT AND WHITE MEMORIAL HOSPITAL (United States)

e SAINT LOUIS UNIVERSITY (United States)

f Och Spine at New York Presbyterian Hospitals (United States)

Author keywords

Infusional chemotherapy; Phase II trial; Sarcoma; Southwest Oncology Group; Topotecan

Indexed keywords

TOPOTECAN;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; DRUG EFFICACY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SOFT TISSUE SARCOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; SARCOMA; TOPOTECAN;

EID: 0036207525 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: 10.1023/A:1014461611890 Document Type: Article

Times cited : (20)

References (8)

1
- 0027280571
- An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas
- (1993) J Clin Oncol , vol.11 , Issue.7 , pp. 1276-1285
- Antman, K.¹ Crowley, J.² Balcerzak, S.P.³ Rivkin, S.E.⁴ Weiss, G.R.⁵ Elias, A.⁶ Natale, R.B.⁷ Cooper, R.M.⁸ Barlogie, B.⁹ Trump, D.L.¹⁰ Doroshow, J.H.¹¹ Aisner, J.¹² Pugh, R.P.¹³ Weiss, R.B.¹⁴ Cooper, B.A.¹⁵ Clamond, G.H.¹⁶ Baker, L.H.¹⁷

2
- 0023176119
- Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas
- (1987) J Clin Oncol , vol.5 , Issue.6 , pp. 840-850
- Borden, E.C.¹ Amato, D.A.² Rosenbaum, C.³ Enterline, H.T.⁴ Shiraki, M.J.⁵ Creech, R.H.⁶ Lerner, H.J.⁷ Carbone, P.P.⁸

3
- 0028793342
- Phase II study of topotecan (NSC 609 699) in patients with recurrent or metastatic soft tissue sarcoma
- (1995) Ann Oncol , vol.6 , Issue.8 , pp. 847-849
- Bramwell, V.H.¹ Eisenhauer, E.A.² Blackstein, M.³ Boos, G.⁴ Knowling, M.⁵ Jolivet, J.⁶ Bogues, W.⁷

4
- 0029116438
- Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors
- (1995) Cancer Chemother Pharmacol , vol.36 , Issue.5 , pp. 393-403
- Houghton, P.J.¹ Cheshire, P.J.² Hallman II, J.D.³ Lutz, L.⁴ Friedman, H.S.⁵ Danks, M.K.⁶ Houghton, J.A.⁷

5
- 0028357995
- Phase I trial of low-dose continuous topotecan infusion in patients with cancer: An active and well-tolerated regimen
- (1994) J Clin Oncol , vol.12 , Issue.3 , pp. 553-559
- Hochster, H.¹ Liebes, L.² Speyer, J.³ Sorich, J.⁴ Taubes, B.⁵ Oratz, R.⁶ Wernz, J.⁷ Chachoua, A.⁸ Raphael, B.⁹ Vinci, R.Z.¹⁰ Blum, R.H.¹¹

6
- 0027076295
- Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria
- (1992) Invest New Drugs , vol.10 , pp. 239-253
- Green, S.¹

7
- 33845382806
- Nonparametric observation from incomplete observations
- (1958) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.¹ Meier, P.²

8
- 0031824583
- Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays
- (1998) Clin Cancer Res , vol.4 , Issue.8 , pp. 1995-2002
- Pawlik, C.A.¹ Houghton, P.J.² Stewart, C.F.³ Cheshire, P.J.⁴ Richmond, L.B.⁵ Danks, M.K.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.